Introduced
Committee
Markup
Reported
Floor
Passed
Enacted
S.604 118th Congress

Changing the Culture of the FDA Act

Status
Dead
Official Source
Investability
40/100
Stage
COMMITTEE
Related Bills
0
Full Text
1,241 chars
Alive
No
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
118 S604 IS: Changing the Culture of the FDA Act U.S. Senate 2023-03-01 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. II 118th CONGRESS 1st Session S. 604 IN THE SENATE OF THE UNITED STATES March 1, 2023 Mr. Manchin (for himself and Mr. Braun ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration. 1. Short title This Act may be cited as the Changing the Culture of the FDA Act . 2. Mission Statement of the Food and Drug Administration The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall amend the mission statement of the Food and Drug Administration to include the following statement: The FDA is also responsible for protecting the public health by strongly considering the danger of addiction and overdose death associated with prescription opioid medications when approving these medications and when regulating the manufacturing, marketing, and distribution of opioid medications. .
🔒 GovGreed Pro · Trading Intelligence on S.604 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated recently.
Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records.
GovGreed is not affiliated with the U.S. Government. Not financial advice.